ArticleResearch and practice in thrombosis and haemostasis2026
The impact of symptom duration on D-dimer: results from the Venous Thrombosis Registry in Østfold Hospital.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It has been suggested that D-dimer testing should be avoided in patients with prolonged symptoms, as results may yield false negatives. However, the evidence supporting this recommendation is limited. Objectives: This study evaluated the impact of symptom duration on D-dimer and investigated associations between false-negative D-dimer results and prolonged symptoms. Methods: Patients diagnosed with pulmonary embolism, deep vein thrombosis (DVT), or upper extremity DVT between 2005 and 2020 were identified through the Venous Thrombosis Registry in Results: In total 3423 patients were included, of whom 1696 (49.5%) were women, with a median age of 67 years (IQR, 54-78 years). The median symptom duration was 4 days (IQR, 2-10 days), and 946 patients (27.6%) reported symptoms exceeding 1 week. D-dimer showed a weak negative correlation with symptom duration (Kendall τ coefficient = -0.04; Conclusion: Although D-dimer were negatively correlated with symptom duration, the coefficient was very weak and unlikely to have clinical relevance. Moreover, false-negative D-dimer results were not associated with prolonged symptoms, suggesting that extended symptom duration may not affect the performance of D-dimer testing in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.